Geneesmiddelenbeleid

This procedure concerns a motion in the Dutch House of Representatives regarding the national pharmaceutical policy. It aims to address the management, accessibility, and strategic direction of medicinal products within the healthcare system. The motion primarily affects the healthcare sector, pharmaceutical providers, and patients by potentially altering how medicines are procured or regulated in the Netherlands.